Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Is there a difference between patients with peak oxygen consumption during exercise below 10 ml/kg/min and between 10 and 14 ml/kg/min? Does the „grey zone” really exist?

M Lizak, M Zakliczyński, A Jarosz, A Barańska-Kosakowska, M Zembala

Ann Transplant 2009; 14(1): 32-32 :: ID: 880523


Background: Maximal oxygen uptake is an important component of evaluation when orthotopic heart transplantation (OHT) in a chronic heart failure patient is considered. Authors call into question the accuracy of peak oxygen consumption during exercise (V02max) interpretation used at present.
Material/Methods: 302 patients with chronic heart failure were analysed in 3 groups according to V02max (ml/kg/min) - group 1: <10 (37 patients), group 2: 10-14 (121 patients), group 3: >14 (144 patients). Mean observation time was 3.41 years. Mortality, number of OHT, time to OHT if transplantation was performed, time to death and pulmonary function tests (PFT) were compared between the groups. ANOVA rang Kruskan-Wallis test was used for analysis in Statistica 7.1.
Results: There were no important differences in mortality (48.6 vs. 33.1%), number of OHT (24.3 vs. 32.2%), time to OHT (4.6 vs. 6.9 months), time to death (15.4 vs. 16.6 months) or pulmonary function tests (forced expiratory volume in the first second - FEV1: 2.29 vs. 2.58l and 69 vs. 77%, forced vital capacity - FVC: 2.97 vs. 3.32l and 73 vs. 81%, FEV1 to FVC ratio - FEV1%FVC: 76 vs. 77%, peak expiratory fl ow - PEF: 6.06 vs. 6.19l and 73 vs. 75%, all given as direct values and as percents of normal values) between group 1 and 2 (p>0.05) but group's 3 mortality (21.5%), number of OHT (14.6%), time to death (34.4 months) and pulmonary function tests (FEV1: 3.10l and 88%, FVC: 3.94l and 91%, PEF: 7.40l and 87%) differed significantly when compared to groups 1 and 2 (p<0.05). Percent of vital capacity normal value (VC%) differed significantly between all the groups (72 vs. 81 vs. 91% accordingly).
Conclusions: No convincing reasons to feel less worried about patients with V02max between 10-14 then below 10 ml/kg/min were found in this research. Analysis of PFT could show additional specifi c risk factors in the chronic heart failure.

Keywords: Heart Transplantation, clinical outcome

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358